Canada markets closed

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4900+0.1200 (+8.76%)
At close: 04:00PM EDT
1.4899 -0.00 (-0.01%)
After hours: 07:26PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 287.15M
Enterprise Value 292.34M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.32
Price/Book (mrq)N/A
Enterprise Value/Revenue 1.50
Enterprise Value/EBITDA -72.24

Trading Information

Stock Price History

Beta (5Y Monthly) 0.84
52-Week Change 322.64%
S&P500 52-Week Change 322.38%
52 Week High 32.4800
52 Week Low 30.7800
50-Day Moving Average 31.5598
200-Day Moving Average 31.3258

Share Statistics

Avg Vol (3 month) 35.04M
Avg Vol (10 day) 32.59M
Shares Outstanding 5209.6M
Implied Shares Outstanding 6209.6M
Float 8190.2M
% Held by Insiders 11.93%
% Held by Institutions 126.61%
Shares Short (Apr 15, 2024) 413.69M
Short Ratio (Apr 15, 2024) 41.42
Short % of Float (Apr 15, 2024) 46.60%
Short % of Shares Outstanding (Apr 15, 2024) 46.53%
Shares Short (prior month Mar 15, 2024) 410.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -26.68%
Operating Margin (ttm)5.26%

Management Effectiveness

Return on Assets (ttm)-9.31%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)194.62M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)0.70%
Gross Profit (ttm)N/A
EBITDA -6.87M
Net Income Avi to Common (ttm)-51.92M
Diluted EPS (ttm)-0.2800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)42.92M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)104.18M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.18
Book Value Per Share (mrq)-0.16

Cash Flow Statement

Operating Cash Flow (ttm)-23.38M
Levered Free Cash Flow (ttm)22.11M